Declaration of the Rights of People Affected by TB launched

The launch of the Declaration is a significant step in recognizing the urgent need to adopt a human rights-based approach to TB and fund human rights-based interventions that overcome barriers to universal access.

Read More →

Community capacity building modules to accelerate DR-TB response

Community capacity building modules to accelerate the response to drug-resistant TB launched at WHO meeting of national TB program managers and partners in the South-East Asia region.

Read More →

Research, regulatory, and access considerations regarding pretomanid

TB CAB releases document outlining key considerations regarding pretomanid in anticipation of FDA public advisory committee meeting on the TB Alliance's new drug application for pretomanid.

Read More →

Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB

Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.

Read More →

It’s Time to End Drug-Resistant Tuberculosis: The Case for Action

The cost of complacency: Economist Intelligence Unit report underscores major gaps in world’s response to drug-resistant TB.

Read More →

Ad-hoc donations of bedaquiline threaten sustainable, affordable access for patients

Advocates call on Indian Minister of Health to discontinue and phase out the drug donations of bedaquiline offered by Johnson & Johnson.

Read More →

An Activist’s Guide to Rifapentine

The guide details important efficacy, safety, and access information on rifapentine, a game-changing drug for treating TB infection in order to prevent active TB disease.

Read More →

Call to action: Pledge your support for the Global Fund

Sign the petition to urge governments to fully replenish the Global Fund!

Read More →

New report calls for urgent action to avert antimicrobial resistance crisis

International organizations unite on critical recommendations to combat drug-resistant infections and prevent staggering number of deaths each year.

Read More →

MSF: Johnson & Johnson should make TB drug available for all at $1/day

MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving TB drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.

Read More →

Page 1 of 97 · Total posts: 10

1 2 Last→